Process for the preparation of (-)-epicatechin from a new natural source namely Dichrostachys cinerea
Granted 11 Jan 2005 · no office action yet
Assignee: Council of Scientific and Industrial Research
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Janaswamy Madhusudana Rao, Rao Jagadeeshwar Rao, Jhillu Singh Yadav, Kondapuram Vijaya Raghavan · Examiner: Taofiq Solola · AU 1626 · TC 1600
Life of the application
6 dated eventsAbstract
This invention relates to a process for isolating (−)-epicatechin from a new plant source namely Dichrostachys cinerea in significant yield.
Description
6 parts›FIELD OF THE INVENTION
This invention relates to the isolation of a compound namely (−)-epicatechin from a new plant source, Dichrostachys cinerea in good yield.
›BACKGROUND ART
Dichrostachys cinerea is a medicinal plant used in the traditional Indian system of medicine and is widely advocated in diuretic, lithotriptic, anodyne, digestive, constipating, and inflammatory conditions. Also it is useful in vitiated conditions of kapha and vata, arthralgia, elephantiasis, dyspepsia, diarrhea, vesicle calculi, strangury, nephropathy, vaginopathy and metropathy.( Indian Medicinal Plants , Vol.2 p.330). It is useful in opthalmia, rheumatism, urinary calculi and renal troubles.( Wealth of India Vol.3 p.56). It is further reported to possess protease inhibitor activity(CA, 90, 118086u), fungi toxic activity ( Ind. J. plant. Physiol, 1986, 29(3), 278-80.), antibacterial ( Fitoterapia, 1988, 59(1), 57-62.). Hence it becomes pertinent to look for the molecules possessing such important biological properties. In this connection, the phytochemical investigation of Dichrostachys cinerea has been taken up. The applicants made efforts for the isolation of a compound (−)-epicatechin in highly economical yield.
›OBJECTS OF THE INVENTION
The main object of the invention is to provide a process for preparation of (−)-epicatechin from a new natural source Dichrostachys cinerea.
Another object of invention is to provide a new source for obtaining (−)-epicatechin in good yield.
(−)-Epicatechin known to posses several activities, which are shown in Table.1
›SUMMARY OF THE INVENTION
The present invention relates to a process for the isolation of (−)-epicatechin from D. cinerea.
›BRIEF DESCRIPTION OF DRAWING
FIG. 1 represents the structure of (−) -epicatechin.
›DETAILED DESCRIPTION
The present invention provides a process for isolation of (−)-epicatechin from D. cinerea comprises of the following steps:
(a) extracting dried wood powder of Dichrostachys cinerea with hexane; (b) extracting the residue of step (a) with chloroform; (c) extracting the residue of step (b) with methanol; (d) concentrating the methanol solution from step (c) under vacuum; (e) adsorbing the methanol extract on silica gel (60-120 mesh) and loading on silica gel (60-120 mesh) column (5 cm diameter to height of 100 cm); (f) eluting the column with chloroform methanol gradient, (g) collecting the fraction eluted at 6% methanol in chloroform, and (h) concentrating the eluted fraction to obtain pure (−)-epicatechin.
In another embodiment of the present invention, the solvent used or selected from Hexane, Chloroform and Methanol.
In another embodiment of the present invention, the yield of (−)-epicatechin obtained is about 0.45% of the dried material. The percentage recited herein is % by weight.
The invention further provides a method for the isolation of (−)-epicatechin from a new plant source namely Dichrostachys cinerea.
In accordance with this invention, it has been found that (−)-epicatechin is isolated from a new plant source, Dichrostachys cinerea in significant yield.
In another invention the process of isolation of (−)-epicatechin is highly economical. Dichrostachys cinerea hence is a new plant source for (−)-epicatechin and its presence in this plant in good yields makes this invention more important. The different plant sources from where (−)-epicatechin is isolated are given in Table. 2.
Experimental protocol: A process for the isolation of compound (−)-epicatechin. The dried stem bark powder of Dichrostachys cinerea (2 Kg) was loaded on a soxhlet apparatus. The powder was first extracted with hexane. The residue from the extraction of hexane was further extracted with chloroform. After the chloroform extraction the residue was taken in a conical flask and soaked in methanol at room temperature. The methanol solution was filtered and concentrated under vacuum (50 g). The methanol extract (50 g) was adsorbed on silica gel (60-120 mesh) and loaded on silica gel (60-120 mesh) column. (5 cms diameter to a height of 100 cms).
The column is subjected to elution with chloroform-methanol gradient. The chloroform-methanol gradient is so selected to obtain specific fraction and thereby the desired compound. In the present case, the fractions eluted at 6% methanol in chloroform are collected separately and concentrated.
The above fractions are subjected to further purification using silica gel column (>200 mesh, 3 cm. dia and 50 cm. length) using chloroform methanol gradient. The eluent at 6% methanol in chloroform gave pure (−)-epicatechin (9.0 g). The spectrochemical data of (−)-epicatechin are given below:
(−)-Epicatechin
1. Molecular formula: C 15 H 14 O 6
2. 1 HNMR: [(CD 3 ) 2 CO; 200 MHz]:δ 7.04 (1H, d, J 2 Hz, H-2 1 ), 6.86 (1H, d, J 8 Hz, H-5 1 ), 6.78 (1H, dd, J2 and 8 Hz, H-6 1 ), 6.22 (1H, d, J2 Hz, H-8), 6.12
3. (1H, d, J2 Hz, H-6),4.88 (1H, s, H-2), 4.20 (1H, m, H-3), 2.80 (2H, m, H-4, H-4′);
4. 13 C NMR [(CD 3 ) 2 CO]: δ 78.13 (C-2), 65.01 (C-3), 28.22 (C-4), 156.57 (C-5), 95.27 (C-6), 156.29 (C-7), 94.22 (C-8), 155.79 (C-9), 98.62 (C-10), 130.69 (C-1 1 ), 118.05 (C-2 1 ), 144.47 (C-3 1 ), 144.54 (C-4 1 ), 114.97(C-5 1 ), 114.90 (C-6 1 ).
5. EIMS: 290 (M + ), 272, 152, 139, and 124.
6. IR ν max (KBr) cm −1 : 3306
7. [α] D 25-68 ° (c 0.1, MeOH)
›Tables in the description — 1
| Compound | Activity | Reference | |
| (−)-Epicatechin | 1. | Anti-viral activity | CA 89: 192312k |
| 2. | Anti-diabetic activity | Indian Drugs, 1981, | |
| 18(5), 184-5 | |||
| 3. | Inhibitory effects on lipid | Chem. Pharm. Bull, | |
| peroxidation in mitochondria | 1983, 31(5), 1625 | ||
| and microcosms of Liver | |||
| 4. | Inhibition of angiotension-I- | Planta Med, 1987, | |
| converting enzyme | 53(1), 12-15 | ||
| 5. | Inhibition of HIV-1 reverse | Bio Chem. Jour, | |
| transcriptase by catechins | 1992, 288(3), | ||
| 717-719 | |||
| 6. | Antioxidant activity | J.Chem.Soc.perkin | |
| trans 2, 1998, 4, | |||
| 911-15 |
Claims as granted
2 claimsLog in to read the claims of this application.
Log in to unlockClassifications
2 codes- C07D311/62
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this application are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockDocuments
Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.
Log in to unlockChain of title
See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.
Log in to unlock